{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:20:39Z","timestamp":1792106439089,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["2023-UNBACLE0245523"],"award-info":[{"award-number":["2023-UNBACLE0245523"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["CA21130"],"award-info":[{"award-number":["CA21130"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005362","name":"University of Bari","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119646","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:19:22Z","timestamp":1781723962000},"page":"119646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammation"],"prefix":"10.1016","volume":"201","author":[{"given":"Imane","family":"Ghafir El Idrissi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1171-0169","authenticated-orcid":false,"given":"David Moreira","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo Pi\u00f1a","family":"M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-9929","authenticated-orcid":false,"given":"Elena","family":"Adinolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Volpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8383-0813","authenticated-orcid":false,"given":"Michela","family":"Buccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Francucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro Leonardo","family":"Pierri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-884X","authenticated-orcid":false,"given":"Carmen","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Leopoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-1979","authenticated-orcid":false,"given":"Jos\u00e8","family":"Brea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialessandra","family":"Contino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2443-1174","authenticated-orcid":false,"given":"Enza","family":"Lacivita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2026.119646_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11011-025-01631-9","article-title":"Microglial activation as a hallmark of neuroinflammation in Alzheimer's disease","volume":"40","author":"Ebrahimi","year":"2025","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119646_bib3","article-title":"Alzheimer's disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.biopha.2026.119646_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119646_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-024-03015-9","article-title":"Taming microglia: the promise of engineered microglia in treating neurological diseases","volume":"21","author":"Luo","year":"2024","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.biopha.2026.119646_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/function\/zqae019","article-title":"The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia","volume":"5","author":"Falzoni","year":"2024","journal-title":"Function"},{"key":"10.1016\/j.biopha.2026.119646_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.617036","article-title":"P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches","volume":"15","author":"Territo","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2026.119646_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","article-title":"The P2X7 receptor: A main player in inflammation","volume":"151","author":"Adinolfi","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119646_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/cells13020161","article-title":"Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human","volume":"13","author":"Tewari","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib11","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1038\/s41598-019-42931-2","article-title":"Amyloid \u03b2-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine","volume":"9","author":"Chiozzi","year":"2019","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2026.119646_bib12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2174\/0929867330666230403094538","article-title":"Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists","volume":"31","author":"El Idrissi","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"17","key":"10.1016\/j.biopha.2026.119646_bib13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/WNR.0b013e3283179333","article-title":"Block of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer\u2019s disease","volume":"19","author":"Ryu","year":"2008","journal-title":"Neuroreport"},{"issue":"7","key":"10.1016\/j.biopha.2026.119646_bib14","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.neurobiolaging.2015.03.015","article-title":"P2X7 receptor is critical in \u03b1-synuclein\u2013mediated microglial NADPH oxidase activation","volume":"36","author":"Jiang","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2026.119646_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fncel.2017.00249","article-title":"P2X7 Receptor activation modulates autophagy in SOD1-G93A mouse microglia","volume":"11","author":"Fabbrizio","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s10194-024-01807-1","article-title":"The effect of P2X7 antagonism on subcortical spread of optogenetically-triggered cortical spreading depression and neuroinflammation","volume":"25","author":"Uzay","year":"2024","journal-title":"J. Headache Pain."},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ijms22010019","article-title":"CB2 Receptor in Microglia: The Guardian of Self-Control","volume":"22","author":"Komorowska-M\u00fcller","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119646_bib19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41401-020-00530-2","article-title":"The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders","volume":"41","author":"Xin","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.biopha.2026.119646_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41419-024-07249-6","article-title":"Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer's disease mice by controlling astrocyte activation","volume":"15","author":"Sobue","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119646_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115109","article-title":"N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)","volume":"248","author":"Graziano","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"37","key":"10.1016\/j.biopha.2026.119646_bib22","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1523\/JNEUROSCI.2419-04.2004","article-title":"ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase","volume":"24","author":"Walter","year":"2004","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119646_bib23","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1073\/pnas.0306707101","article-title":"P2X7 receptors control 2-arachidonoylglycerol production by microglial cells","volume":"101","author":"Witting","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119646_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"key":"10.1016\/j.biopha.2026.119646_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1061220","article-title":"Spinal cannabinoid receptor 2 activation alleviates neuropathic pain by regulating microglia and suppressing P2X7 receptor","volume":"16","author":"Zhou","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119646_bib26","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1158\/0008-5472.CAN-11-1947","article-title":"Expression of P2X7 receptor increases in vivo tumor growth","volume":"72","author":"Adinolfi","year":"2012","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.biopha.2026.119646_bib27","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1021\/acs.jmedchem.7b00155","article-title":"Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure-Affinity Relationship (SAfiR) and Structure-Activity Relationship (SAR) Studies","volume":"60","author":"Spinelli","year":"2017","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41419-025-07897-2","article-title":"P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: Role of the A2A\/CD39\/CD73 axis","volume":"16","author":"Pegoraro","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119646_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31186","article-title":"The P2X7 receptor forms a dye-permeable pore independent of its intracellular domain but dependent on membrane lipid composition","volume":"6","author":"Karasawa","year":"2017","journal-title":"Elife"},{"issue":"21","key":"10.1016\/j.biopha.2026.119646_bib30","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3390\/cells12212570","article-title":"Microglia Depletion Attenuates the Pro-Resolving Activity of the Formyl Peptide Receptor 2 Agonist AMS21 Related to Inhibition of Inflammasome NLRP3 Signalling Pathway: A Study of Organotypic Hippocampal Cultures","volume":"12","author":"Tylek","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119646_bib31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22153","article-title":"Structural basis for subtype-specific inhibition of the P2X7 receptor","volume":"5","author":"Karasawa","year":"2016","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.biopha.2026.119646_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2018.12.011","article-title":"Crystal Structure of the Human Cannabinoid Receptor CB2","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2026.119646_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2020.01.008","article-title":"Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures","volume":"180","author":"Hua","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119646_bib34","unstructured":"OBABEL: \u3008https:\/\/link.springer.com\/article\/10.1186\/1758-2946-3-33\u3009."},{"key":"10.1016\/j.biopha.2026.119646_bib35","unstructured":"Autodock: \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/19399780\/\u3009."},{"key":"10.1016\/j.biopha.2026.119646_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bcp.2015.11.019","article-title":"Identification of new highly selective inhibitors of the human ADP\/ATP carriers by molecular docking and in vitro transport assays","volume":"100","author":"Todisco","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119646_bib37","doi-asserted-by":"crossref","unstructured":"Cafferati Beltrame L., Todisco S., Francavilla A.L., Mangini V., Bombino E., Sciancalepore A.G., Scaglione V., Sgobba M.N., Trisolini L., Laera L., Colella F., Spadone S., Belviso B.D., Guerra L., De Grassi A., Caliandro R., De Stradis A., Volpicella M., Pierri C.L. Discovery of therapeutic AGC2 modulators by combining docking, binding, and vesicle-based transport assays. J Transl Med. 2025 Oct 1;23(1):1033. doi: 10.1186\/s12967-025-06961-x. Erratum in: J Transl Med. 2025 Oct 29;23(1):1194. doi: 10.1186\/s12967-025-07285-6.","DOI":"10.1186\/s12967-025-06961-x"},{"key":"10.1016\/j.biopha.2026.119646_bib38","first-page":"1123","article-title":"Combined in silico\/in vitro approaches for identifying modulators of the activity of the p.Tyr110Cys Carnitine O-Acetyltransferase (CRAT) variant associated to an early onset case of Leigh syndrome","volume":"46","author":"Cafferati Beltrame","year":"2025"},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12864-019-5549-9","article-title":"A modular analysis of microglia gene expression, insights into the aged phenotype","volume":"20","author":"Cho","year":"2019","journal-title":"BMC Genom."},{"issue":"12","key":"10.1016\/j.biopha.2026.119646_bib40","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119646_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2011.09.061","article-title":"Interferon modulates central nervous system function","volume":"1442","author":"Reyes-V\u00e1zquez","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2026.119646_bib42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fneur.2018.00458","article-title":"Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application","volume":"9","author":"Roselli","year":"2018","journal-title":"Front. Neurol."},{"issue":"20","key":"10.1016\/j.biopha.2026.119646_bib43","doi-asserted-by":"crossref","first-page":"9730","DOI":"10.1073\/pnas.90.20.9730","article-title":"Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide","volume":"90","author":"Lowenstein","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/IAI.67.1.206-212.1999","article-title":"Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1","volume":"67","author":"Held","year":"1999","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biopha.2026.119646_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/aps.2016.149","article-title":"Brain cannabinoid receptor 2: expression, function and modulation","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2026.119646_bib46","article-title":"Preparation of Tetrahydro[1,2,4]triazolo[4,3-a]pyrazine Derivatives for Use as P2X7 Modulators","volume":"2010125102","author":"Dean","year":"2010","journal-title":"WO"},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12974-018-1353-8","article-title":"A central role for P2X7 receptors in human microglia","volume":"15","author":"Janks","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119646_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tins.2013.12.001","article-title":"The human side of microglia","volume":"37","author":"Smith","year":"2014","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119646_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12974-018-1288-0","article-title":"The human microglial HMC3 cell line: where do we stand? A systematic literature review","volume":"15","author":"Dello Russo","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.biopha.2026.119646_bib50","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.bjp.0705529","article-title":"Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells","volume":"140","author":"Zoratti","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119646_bib51","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1073\/pnas.1118167109","article-title":"Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors","volume":"109","author":"den Boon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2026.119646_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2008.11.047","article-title":"Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins","volume":"603","author":"Malysz","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"6753","key":"10.1016\/j.biopha.2026.119646_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.adx0043","article-title":"Neuroinflammation across neurological diseases","volume":"388","author":"Shi","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119646_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102638","article-title":"Glial polarization in neurological diseases: Molecular mechanisms and therapeutic opportunities","volume":"104","author":"Liu","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119646_bib55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Komorowska-M\u00fcller","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119646_bib56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: therapeutic implications","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119646_bib57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J. Neuroinflamm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:39:56Z","timestamp":1784529596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["S0753332226006827"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119646","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119646"}}